Healthtech Off The Record

Who Will Be the "OpenEvidence of Europe"? Market Map and Critical Questions

OpenEvidence’s $150 million ARR and $12 billion valuation have sparked a debate about a European equivalent. Europe boasts over 2.3 million licensed physicians—roughly twice the U.S. pool—but linguistic and regulatory fragmentation hampers continent‑wide scaling. A crowded field of startups, incumbents like UpToDate, and AI‑driven rivals such as Heidi intensifies the competitive landscape, making execution and strategic partnerships the primary moats. Monetization remains uncertain, as ad‑based models that thrive in the U.S. face lower pharma budgets and stricter European advertising rules.